MedTrace Logo

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

NCT05050877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 184855

Last updated 2021-09-21

No results posted yet for this study

Summary

As a multi-center, retrospective observation study in southern China, this study included the main study population of patients who underwent coronary angiography at 5 hospitals from Guangzhou, Shenzhen, Yangjiang, Maoming and Longyan from January 2000 to Decemeber 2020. The hospitalization information was collected in the form of direct derivation of the case, and cardiac and renal adverse events were collected through outpatient system. Data on all-cause death were obtained from the Guangdong Provincial Public Security and matched to the electronic Clinical Management System of the Guangdong Provincial People's Hospital records.

Conditions

Sponsors & Collaborators

  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER

  • Maoming Hospital Affiliated to Southern Medical University

    collaborator UNKNOWN

  • Shenzhen People's Hospital

    collaborator OTHER

  • Yangjiang People's Hospital

    collaborator OTHER

  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Yong Liu, MD,PhD · Guangdong Cardiovascular Institute,Guangdong Provincial People's Hospital

  • Shiqun Chen, MS · Guangdong Cardiovascular Institute,Guangdong Provincial People's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-06-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050877 on ClinicalTrials.gov